3.14
price down icon2.18%   -0.07
after-market Dopo l'orario di chiusura: 3.12 -0.02 -0.64%
loading

Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie

pulisher
05:01 AM

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Rocket - GlobeNewswire

05:01 AM
pulisher
04:59 AM

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT - GlobeNewswire Inc.

04:59 AM
pulisher
03:02 AM

Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours - Benzinga

03:02 AM
pulisher
03:00 AM

Rocket Pharmaceuticals (RCKT) Target Price Lowered by Canaccord Genuity | RCKT Stock News - GuruFocus

03:00 AM
pulisher
02:14 AM

Rocket Pharmaceuticals Inc. Equity Warrant Stock Analysis and ForecastFree Predictions - PrintWeekIndia

02:14 AM
pulisher
01:34 AM

FDA Clinical Hold on RP-A501 Trial Triggers Rocket - GlobeNewswire

01:34 AM
pulisher
12:02 PM

Deadline Alert: Rocket Pharmaceuticals, Inc. (RCKT) - GlobeNewswire

12:02 PM
pulisher
11:40 AM

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - FinancialContent

11:40 AM
pulisher
11:38 AM

Rocket Pharmaceuticals Inc. Stock Analysis and ForecastHigh-octane financial growth - PrintWeekIndia

11:38 AM
pulisher
10:50 AM

Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky to Join Class Action Before August 11, 2025 - ACCESS Newswire

10:50 AM
pulisher
08:45 AM

Levi & Korsinsky Reminds Rocket Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025RCKT - WV News

08:45 AM
pulisher
Jul 24, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

Levi & Korsinsky Urges Rocket Pharmaceuticals, Inc. (RCKT) Shareholders to Act Before Lead Plaintiff Deadline August 11, 2025 - Barchart.com

Jul 24, 2025
pulisher
Jul 24, 2025

Investor Alert: Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Trial Safety Concerns - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Rocket Pharmaceuticals Inc. Equity Warrant stockAccelerated investment success - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals to cut 30% of workforce - NJBIZ

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharma falls on delay of certain drug development programs - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals (RCKT) Restructures, Cuts Workforce by 30% - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals cuts headcount, realigns pipeline - Seeking Alpha

Jul 24, 2025
pulisher
Jul 24, 2025

The Fragile Equilibrium: Assessing Rocket Pharmaceuticals Amid Securities Litigation and Governance Concerns - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

RCKT LAWSUIT ALERT: The Gross Law Firm Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals (RCKT) Restructures for Strategic Focus a - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals Announces Strategic Reorganization - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals cuts workforce by 30% to focus on heart therapies - Investing.com Australia

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals Announces Strategic Corporate Reorganizat - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs - Business Wire

Jul 24, 2025
pulisher
Jul 23, 2025

Rocket Pharmaceuticals Announces Strategic Reorganization Plan - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join Class Action Before August 11, 2025Contact Levi & Korsinsky - Barchart.com

Jul 23, 2025
pulisher
Jul 23, 2025

Investor Alert: Securities Class Action Filed Against Rocket Pharmaceuticals (RCKT) - TradingView

Jul 23, 2025
pulisher
Jul 23, 2025

RCKT Class Action Reminder: Robbins LLP Reminds Rocket Pharmaceuticals, Inc. Investors of the Class Action LawsuitContact us for more information - Morningstar

Jul 23, 2025
pulisher
Jul 23, 2025

RCKT INVESTOR ALERT: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options - PR Newswire

Jul 23, 2025
pulisher
Jul 23, 2025

Signaturefd LLC Increases Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - StreetInsider

Jul 22, 2025
pulisher
Jul 22, 2025

Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. (RCKT) Shareholders of Class Action Lawsuit and August 11, 2025 Deadline - Barchart.com

Jul 22, 2025
pulisher
Jul 22, 2025

Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop - TradingView

Jul 22, 2025
pulisher
Jul 22, 2025

ROSEN, A TOP RANKED LAW FIRM, Encourages Rocket - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class ActionHagens Berman - TradingView

Jul 22, 2025
pulisher
Jul 22, 2025

Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Rocket Pharmaceuticals Inc. Equity Warrant stock priceTremendous growth potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Join - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

ROCKET PHARMACEUTICALS, INC. (NASDAQ: RCKT) SHAREHOLDER - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

Rocket Pharmaceuticals Inc (RCKT) Stock: Navigating a Year of Stock Volatility - investchronicle.com

Jul 21, 2025
pulisher
Jul 21, 2025

Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT)August 11, 2025 Deadline to JoinContact The Gross Law Firm - PR Newswire

Jul 21, 2025
pulisher
Jul 21, 2025

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

Jul 21, 2025
pulisher
Jul 20, 2025

Is Rocket Pharmaceuticals Inc. a good long term investmentAccelerated capital growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

2025-07-20 | Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky to Join Class Action Before August 11, 2025 | NDAQ:RCKT | Press Release - Stockhouse

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about Rocket Pharmaceuticals Inc. stockRapid-fire capital growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire

Jul 20, 2025
pulisher
Jul 20, 2025

2025-07-20 | RCKT LAWSUIT ALERT: Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. InvestorsLead Plaintiff Deadline August 11, 2025 | NDAQ:RCKT | Press Release - Stockhouse

Jul 20, 2025
pulisher
Jul 19, 2025

2025-07-19 | RCKT ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Rocket Pharmaceuticals, Inc.August 11, 2025 Deadline | NDAQ:RCKT | Press Release - Stockhouse

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Rocket Pharmaceuticals Inc. stock priceHigh-profit trading signals - Jammu Links News

Jul 19, 2025
pulisher
Jul 19, 2025

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Rocket - GlobeNewswire

Jul 19, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):